Wharton’s Jelly Malaysia research studies how stem cells from umbilical cord tissue may help people with knee osteoarthritis and joint pain. These studies look at whether this treatment is safe and whether it can reduce pain and improve movement.
Research in Malaysia is led by Assoc. Prof Dato’ Dr Badrul Akmal Hisham Bin Md Yusoff, orthopaedic sports surgeon specialising in stem cell therapy, ACL reconstruction and joint preservation and the Managing Director of KL Orthosports.
You may view his academic profile here:
https://www.ukm.my/spsfper/expertukm/dato-dr-badrul-akmal-hisham-md-yusoff/

Wharton’s Jelly–derived stem cells are being studied in Malaysia for:
Cartilage regeneration, pain reduction in osteoarthritis, improved joint mobility and slowing degenerative joint progression.
Published Malaysian research includes:
Sains Malaysiana Journal:
https://doi.org/10.17576/jsm-2023-5210-04
International review on WJ-MSCs:
https://doi.org/10.3390/jfb16030084
All regenerative therapy research must comply with guidelines set by the
Ministry of Health Malaysia
https://www.moh.gov.my
and
National Pharmaceutical Regulatory Agency
https://www.npra.gov.my
Eligibility depends on the clinical study protocol.
Volunteers may include:
Patients with knee osteoarthritis
Individuals with cartilage injury
Patients experiencing chronic joint pain
Candidates suitable for regenerative medicine trials
Each study has strict inclusion and exclusion criteria.
If you are interested in participating:
Submit your interest and register below ![]()
You may undergo:
Medical history review
Physical examination
Imaging (X-ray or MRI)
Laboratory tests
All procedures, potential risks, and follow-up requirements will be clearly explained before enrolment.
Participation in Wharton’s Jelly Malaysia clinical research is voluntary and closely monitored under Good Clinical Practice (GCP) standards.
Stem cell clinical studies in Malaysia operate under strict ethical oversight. Volunteers are carefully monitored throughout the research process.
While regenerative medicine shows promising potential, these treatments remain under structured clinical investigation to ensure safety and effectiveness.